GL1X · GenesisL1 explorer

Research workbench

HIV-1 rt with non-nucleoside inhibitor annulated pyrazole 1

Analyse HIV-1 rt with non-nucleoside inhibitor annulated pyrazole 1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3DYA
Type
protein
Length
953 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H; P51 rt
EC
2.7.7.49, 2.7.7.7, 3.1.26.4
UniProt
P04585
Ligands
PZL
Pockets
13 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse TRANSCRIPTASE/RIBONUCLEASE H (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein55133% helix, 23% strandP04585
BP51 rt (EC 2.7.7.49, 2.7.7.7, 3.1.26.4)protein40239% helix, 18% strandP04585

Ligands and binding sites

  • PZL · 3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111040.790.80123PZL
26930.750.8065empty
32340.650.8340empty
41530.470.7617empty
51350.450.7718empty

Interfaces

1 interface between chains.

  • A–B · 2866 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 3DYA · HIV-1 RT with non-nucleoside inhibitor annulated Pyrazole 1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.